SCHEMBL21137353

SCHEMBL21137353

Cc1ccc2cc[n+](O)cc2c1Br

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21050842 0.78 CYP1A2 (0.31) CYP1A2CYP2A6TSHR
SCHEMBL103139 0.67 CYP2A6 (0.60) CYP1A2CYP2A6TSHR
SCHEMBL29520733 0.67 CYP2A6 (0.60) CYP1A2CYP2A6TSHR
SCHEMBL30640484 0.66 CYP1A2 (0.54) CYP1A2CYP2A6TSHR
SCHEMBL6041439 0.66 TYMS (0.41) CYP1A2CYP2A6TSHR
SCHEMBL3267082 0.66 CYP1A2 (0.54) CYP1A2CYP2A6TSHR
SCHEMBL7530012 0.65 CYP1A2 (0.40) CYP1A2CYP2A6TSHR
SCHEMBL10272141 0.64
SCHEMBL8244435 0.63 CYP19A1 (0.40) CYP1A2TSHR
SCHEMBL13525160 0.63 CYP1A2 (0.33) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed